Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Perspective Therapeutics, Inc. Common Stock (NY: CATX )

3.670 -0.140 (-3.67%)
Streaming Delayed Price Updated: 1:53 PM EST, Jan 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Perspective Therapeutics, Inc. Common Stock

< Previous 1 2 Next >
Perspective Therapeutics Touts Encouraging Updated Data From Gastrointestinal Cancer Trial, Stock Soars
Perspective Therapeutics shares interim results for [212Pb]VMT-α-NET trial, showing promising safety, stable disease cases, and anti-tumor activity. 
Via Benzinga
Here's How Donald Trump Could Shake Up Health Care — And Biotech Stocks
Biotech stocks have slumped 15% since Donald Trump won his second presidency. That's because Trump comes with unknowns. 
Via Investor's Business Daily
Topics Government
Exposures Political
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Dow Jumps Over 100 Points; Nvidia Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Earnings Scheduled For November 12, 2024
Via Benzinga
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
Novartis aims to enhance Pluvicto's market presence while exploring growth in multiple sclerosis and expanding its radioligand therapy portfolio. 
Via Benzinga
Why Perspective Therapeutics (CATX) Shares Are Falling
Perspective Therapeutics shares are trading lower by 12.9% Thursday morning. The company announced the pricing of an underwritten public offering. 
Via Benzinga
S&P 500 Moves Higher; BlackRock Reports Upbeat Results
Via Benzinga
Topics Stocks
Exposures US Equities
Gold Gains 1%; Wells Fargo Shares Gain After Q3 Earnings
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Cancer-Focused Perspective Therapeutics Stock Trades Lower After Drug Study Report
Perspective Therapeutics is down 13% at last check Friday. The downtrend comes as drug study results are presented to medical professionals. 
Via Benzinga
Dow Surges 150 Points; JPMorgan Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
CATX Stock Earnings: Perspective Therapeutics Beats EPS, Beats Revenue for Q2 2024
CATX stock results show that Perspective Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
3 Outperforming Stocks Surpassing Even Nvidia This Year
Given its performance in 2024, there are very few stocks outperforming Nvidia this year. Here are three of them. 
Via InvestorPlace
$1.8M Bet On This Health Care Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
Via Benzinga
Expensify And 2 Other Stocks Under $2 Insiders Are Buying
Via Benzinga
Insider Trading is Good News for These Stocks
Insiders are buying these hot stocks that have ample upside for investors. The list includes pharma, entertainment, and financial stocks and Berkshire buys. 
Via MarketBeat
CATX Stock Earnings: Perspective Therapeutics Meets EPS for Q1 2024
CATX stock results show that Perspective Therapeutics met analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
Stocks Pause As Traders Reassess Interest Rate Path, Gold Makes New Highs, Bitcoin Rebounds: What's Driving Markets Thursday?
In the final session of the short trading week leading up to Easter festivities, U.S. equity indices held steady, reflecting some setbacks in market expectations regarding interest rate reductions. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Expensify And 3 Other Stocks Under $3 Insiders Are Buying
The Dow Jones index closed higher by more than 350 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and... 
Via Benzinga
Topics Stocks
Exposures US Equities
Expensify And 2 Other Stocks Under $2 Insiders Are Buying
The Dow Jones index closed higher by more than 100 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and... 
Via Benzinga
Topics Stocks
Exposures US Equities
Perspective Therapeutics And 3 Other Stocks Under $2 Insiders Are Buying
The Dow Jones index closed higher by around 60 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
GeoVax Labs And 2 Other Stocks Under $2 Insiders Are Buying
The Dow Jones index closed higher by over 150 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.